Patent details
301343
Product Name:
lecanemab
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301343
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2004688
Status:
Application Pending
Application number:
301343
Procedural language:
Dutch
First Applicant Residence Country:
Sweden (SE)
Marketing Authorization
Marketing Authorization Number:
EU/1/24/1891
Marketing Authorization Type:
EEA
Marketing Authorization Date:
15/04/2025
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
12/09/2025
First Marketing Authorization date:
15/04/2025
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
12/09/2025
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
12/09/2025
Name:
BioArctic AB
Address:
Warfvinges väg 35, SE-11251, Stockholm, Sweden (SE)
Agent
Name:
ir. B.Ch. Ledeboer c.s
From:
12/09/2025
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
Bulletin Heading:
SPC
Journal edition number:
38/25
Publication date:
17/09/2025
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
15/09/2025
Outgoing Correspondence
Confirmation receipt request
2
PDF
/2/4/0/0/6/0801160042/docs/301343_8_301343674091l174.pdf
12/09/2025
Application Form
First filed application form
3
PDF
/2/4/0/0/6/0801160042/docs/301343_0_applicationform20250912041242565.pdf
12/09/2025
SPC Documents
Marketing Authorization SPC
3
PDF
/2/4/0/0/6/0801160042/docs/301343_1_supplprotectioncertificate20250912041242613.pdf
12/09/2025
SPC Documents
Annex SPC
2
PDF
/2/4/0/0/6/0801160042/docs/301343_2_supplprotectioncertificate20250912041242664.pdf
12/09/2025
SPC Documents
Summary of the characteristics of the product
17
PDF
/2/4/0/0/6/0801160042/docs/301343_3_supplprotectioncertificate20250912041242621.pdf
12/09/2025
SPC Documents
Accompanying letter SPC
3
PDF
/2/4/0/0/6/0801160042/docs/301343_4_supplprotectioncertificate20250912041242605.pdf
12/09/2025
SPC Documents
Annex SPC
14
PDF
/2/4/0/0/6/0801160042/docs/301343_5_supplprotectioncertificate20250912041242652.pdf
12/09/2025
SPC Documents
Annex SPC
1
PDF
/2/4/0/0/6/0801160042/docs/301343_6_supplprotectioncertificate20250912041242672.pdf
12/09/2025
SPC Documents
Annex SPC
4
PDF
/2/4/0/0/6/0801160042/docs/301343_7_supplprotectioncertificate20250912041242637.pdf